Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exoqure is a South Korean biotechnology company specializing in the development of exosome-based therapeutics for regenerative medicine and inflammatory diseases. The company utilizes a proprietary platform for the isolation and purification of high-purity exosomes derived from stem cells and other biological sources. Exoqure's primary research focus includes treatments for atopic dermatitis and hair loss (alopecia), where exosomes serve as potent signaling vehicles to modulate immune responses and promote tissue repair. By advancing its pipeline through pre-clinical and early clinical stages, Exoqure aims to establish a new paradigm in cell-free regenerative therapy. The company is also exploring the application of its technology in the medical aesthetics and cosmeceutical markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Exoqure.